What is the appropriate management for Ebstein anomaly?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Ebstein Anomaly

All patients with Ebstein anomaly require lifelong specialized surveillance at a tertiary congenital heart disease center, with management stratified by symptom severity, degree of tricuspid regurgitation, right ventricular function, and presence of cyanosis or arrhythmias 1, 2.

Initial Diagnostic Evaluation

Obtain ECG, chest x-ray, and transthoracic echocardiography-Doppler as the foundation of diagnosis 3. The echocardiogram must document:

  • Apical displacement of the septal tricuspid leaflet (>8 mm/m²)
  • Severity of tricuspid regurgitation
  • Right ventricular size and systolic function
  • Right atrial enlargement
  • Presence of atrial septal defect or patent foramen ovale
  • Left ventricular function

Add cardiac magnetic resonance imaging for comprehensive volume assessment of both ventricles, evaluation of tricuspid regurgitation fraction, and right ventricular stroke volume 2. This is particularly valuable for surgical planning and risk stratification.

Perform exercise stress testing with oxygen consumption measurement in all asymptomatic patients to unmask occult exercise intolerance, as many patients underestimate their functional limitation 3, 2.

Order Holter monitoring and electrophysiology study if there is documented or suspected supraventricular arrhythmia or ECG evidence of accessory pathways 3. Remember that approximately 25% of patients have accessory conduction pathways, and nearly 50% have multiple pathways 1.

Medical Management

Anticoagulate with warfarin if there is history of paradoxical embolus or atrial fibrillation 3. This is a Class I recommendation.

For mild Ebstein anomaly without significant symptoms:

  • Follow regularly with a congenital heart disease cardiologist
  • Monitor rhythm status closely given high incidence of supraventricular arrhythmia
  • Use diuretics for peripheral edema in right-sided heart failure, but recognize they will not improve fatigue and dyspnea related to low cardiac output 1, 3
  • Implement goal-directed medical therapy if left ventricular systolic dysfunction develops, after excluding concomitant acquired disease 2

Arrhythmia Management

Attempt catheter ablation for recurrent supraventricular tachycardia before considering surgery, though success rates are lower than in structurally normal hearts due to frequent multiple accessory pathways 1.

Exercise caution with percutaneous ablation in patients with interatrial communication and right-to-left shunt due to paradoxical embolus risk 1.

Perform electrophysiology study before any surgical repair to localize accessory pathways for attempted catheter ablation 1. If ablation fails, surgical interruption can be performed intraoperatively.

Surgical Indications (Class I Recommendations)

Refer to a surgeon with training and expertise in congenital heart disease for tricuspid valve repair or replacement with concomitant ASD closure when present, if ANY of the following are present 1:

  1. Symptoms or deteriorating exercise capacity
  2. Cyanosis (oxygen saturation <90%)
  3. Paradoxical embolism
  4. Progressive cardiomegaly on chest x-ray
  5. Progressive right ventricular dilation or reduction of right ventricular systolic function

Surgery can be beneficial in asymptomatic patients with severe tricuspid regurgitation, moderate right ventricular enlargement, and valve anatomy favorable for repair 2. The recent introduction of cone repair has transformed surgical outcomes and favors earlier intervention to preserve right ventricular function 2, 4.

Surgical Approach

The primary operation consists of:

  • Closure of interatrial communications
  • Antiarrhythmia procedures (surgical division of accessory pathways, cryoablation, or Maze procedure)
  • Tricuspid valve surgery (repair preferred when feasible; replacement with mechanical or bioprosthetic valve when repair not feasible)
  • Right reduction atrioplasty often performed 1

Perform concomitant Maze procedure when there is paroxysmal or continuous atrial fibrillation/flutter 1, 2.

Consider bidirectional cavopulmonary anastomosis (Glenn shunt) when there is severe right ventricular dilation, severe right ventricular systolic dysfunction, right atrial pressure:left atrial pressure ratio >1.5, or failure to separate from cardiopulmonary bypass after repair 1, 2. Recent data shows concomitant Glenn procedure significantly reduces risk of both reoperation and medical intervention 5, 4.

Reserve single-ventricle Fontan pathway for profound right ventricular dysfunction, most often when operation required during infancy 1.

Consider heart transplantation when significant left ventricular dysfunction has occurred (ejection fraction <30%) with important heart failure symptoms 1.

Reoperation Indications

Perform surgical rerepair or replacement for 1:

  • Symptoms, deteriorating exercise capacity, or NYHA class III-IV
  • Severe tricuspid regurgitation after repair with progressive right ventricular dilation, reduced systolic function, or appearance/progression of arrhythmias
  • Bioprosthetic valve dysfunction with significant mixed regurgitation and stenosis
  • Predominant bioprosthetic stenosis (mean gradient >12-15 mmHg)

Note that tricuspid valve replacement or rereplacement is usually required at reoperation; rerepair is rarely successful 1.

Critical Pitfalls to Avoid

  • Do not close an ASD percutaneously without recognizing underlying Ebstein anomaly, as this may alter intervention recommendations 1
  • Do not misdiagnose other causes of tricuspid regurgitation and right heart enlargement (tricuspid dysplasia, prolapse, trauma, arrhythmogenic RV cardiomyopathy, endocarditis, carcinoid) as Ebstein anomaly 3, 1
  • Do not underestimate severity of tricuspid regurgitation due to subtle physical findings and laminar regurgitant flow on echo 3, 1
  • Do not misinterpret right heart enlargement and cyanosis as pulmonary arterial hypertension 1
  • Recognize that multiple accessory pathways should raise suspicion for Ebstein anomaly 1

Long-Term Outcomes

Early mortality is approximately 5-10% in experienced centers, with late survival of 92% at 10 years postoperatively 1. Recent data from centers using individualized strategies with earlier intervention show 5-year survival of 98.5% 4. Preoperative hepatic congestion, Wolff-Parkinson-White syndrome, and elevated ALT are independent risk factors for worse outcomes 5.

All operated patients require lifelong surveillance for recurrent native valve dysfunction, prosthetic valve degeneration, atrial and ventricular arrhythmias, and ventricular dysfunction 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.